Form 4 for NVAX NOVAVAX INC
Accepted 2024-06-14 00:00:00 ET · period of report 2024-06-12 · accession 0001593968-24-000864 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-14 | 2024-06-12 | NVAX | Alton Gregg H | Dir | M - OptEx | $0.00 | +6,670 | 10.5K | +176% | $0 |
| D | 2024-06-14 | 2024-06-12 | NVAX | Alton Gregg H | Dir | M - OptEx | $0.00 | -6,670 | 0 | -100% | $0 |
| DM | 2024-06-14 | 2024-06-12 | NVAX | Alton Gregg H | Dir | A - Grant | $9.52 | +26.1K | 10.4K | New | +$247.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-12 | M | A | 6,670 | $0.00 | 10,470 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2024-06-12 | M | D | 6,670 | $0.00 | 0 | D | $0.00 · 2024-06-12 to 2033-06-12 | 6,670 Common Stock | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-06-12 | A | A | 15,630 | $15.86 | 15,630 | D | $15.86 · 2025-06-12 to 2034-06-12 | 15,630 Common Stock | |
| 4 | Derivative | Restricted Stock Units | 2024-06-12 | A | A | 10,420 | $0.00 | 10,420 | D | $0.00 · 2025-06-12 to 2034-06-12 | 10,420 Common Stock |